ECS Botanics Holdings Ltd (ASX:ECS) Reports Half-Year Financial Results
ECS Botanics Holdings Ltd (ASX:ECS) reports a $1.98m net loss and strategic expansions in export markets and product offerings.
Category: Healthcare
Neurotech International Ltd (ASX:NTI) Receives EMA Positive Opinion
Neurotech International Ltd (ASX:NTI) receives EMA positive opinion for NTI164 in Rett Syndrome, marking a key regulatory milestone.
Monash IVF Group Limited (ASX:MVF) Reports 5.5% Underlying NPAT Growth in 1H25
Monash IVF Group (ASX:MVF) reports 11.6% revenue growth and declares a 2.6c interim dividend for 1H25.
Pacific Smiles Group Limited (ASX:PSQ) Reports 10% Revenue Growth and 52% Underlying Profit Increase for H1
Pacific Smiles Group Limited (ASX:PSQ) reports a 10% revenue increase and a 52% rise in underlying profit for the half-year ended 31 December 2024, alongside a major ownership change.
Telix Pharmaceuticals Limited (ASX:TLX) FDA Accepts BLA for TLX250-CDx
Telix Pharmaceuticals (ASX:TLX) announces FDA acceptance of BLA for TLX250-CDx, targeting kidney cancer imaging with a planned U.S. launch in 2025.
OncoSil Medical Ltd (ASX:OSL) Delivers Key Milestones and Financial Growth in H1 2025
OncoSil Medical Ltd (ASX:OSL) achieves significant clinical and financial milestones, expanding its global presence and enhancing its financial position in H1 2025.
Acrux (ASX:ACR) Reports A$20M Revenue and Announces US Product Launches
Acrux (ASX:ACR) reports A$20 million revenue for FY23-FY24 and announces new US product launches, bolstering its presence in the pharmaceutical market.
Archer Materials Limited (ASX:AXE) Enhances Biochip Feasibility and Advances Development Roadmap
Archer Materials Limited (ASX:AXE) improves Biochip’s potassium detection accuracy, advances to human blood testing, and plans regulatory engagements.
Dimerix Limited (ASX:DXB) Reports Half-Year Financial Results
Dimerix Limited (ASX:DXB) reports a 113% revenue increase in the half-year ended December 2024, alongside a 93% rise in losses.
4DMedical (ASX:4DX) Gains Regulatory Approval for CT LVAS™ in Canada
4DMedical (ASX:4DX) secures Canadian approval for CT LVAS™, expanding its respiratory imaging portfolio and market reach.